iShares has launch a new ETF offering access to biotechnology and pharmaceutical companies from the US. The ETF is traded on Xetra and Börse Frankfurt.
The firm writes that the iShares NASDAQ US Biotechnology UCITS ETF enables investors to participate in the performance of biotechnology and pharmaceutical companies from the US. The index components must be listed on NASDAQ and meet set admission criteria on market capitalisation and liquidity. The maximum weighting of an index component is eight percent. In addition, a maximum of five index components are permitted to reach this limit.